Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced that the first patients have been enrolled in two global Phase III clinical trials — MINT-E (NCT07018700 ...
NORTH CHICAGO, Ill., June 15, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that it has 27 studies accepted to the virtual 2020 Annual ...
Follow-up: At the four-day follow-up, 80% of the improvements held. The patient reported being able to function much more ...
DUBLIN, May 2, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the company will share 29 presentations at the 71 st Annual American Academy of Neurology (AAN) Meeting, including 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback